We use essential cookies and third-party cookies for content.

Pallade Veneta - Medical Components Specialists to Exhibit at Medical Technology Ireland 2025

Medical Components Specialists to Exhibit at Medical Technology Ireland 2025

BOULEVARD 19.09.2025
Medical Components Specialists to Exhibit at Medical Technology Ireland 2025
Medical Components Specialists to Exhibit at Medical Technology Ireland 2025

BELLINGHAM, MASSACHUSETTS / ACCESS Newswire / September 19, 2025 / Medical Components Specialists (MCS), a leading contract manufacturer of precision medical devices, announced its participation in the upcoming Medical Technology Ireland Expo and Conference, taking place September 24-25 at the Galway Racecourse.

Change text size:

Medical Technology Ireland has become Europe's second-largest and fastest-growing medical device design event. This year, the conference is expected to draw more than 2,000 attendees and over 350 exhibitors, showcasing the latest innovations and solutions driving the Irish medtech sector.

Over the course of two days, the conference program will feature sessions on topics including the future of Irish MedTech, unlocking global opportunities through innovation, the Women in MedTech Forum, and advancements in catheter technologies, among others. The event provides a platform for knowledge exchange, networking, and exploration of cutting-edge medical technologies shaping the global healthcare landscape.

Medical Components Specialists will be exhibiting at Booth #98H on the ground floor. With more than 60 years of experience in precision grinding, MCS supplies orthopedic and interventional products, including drills, reamers, guide wires, trocars, catheter mandrels, and input tubes. Its FDA-registered facilities and ISO 13485 certification support full in-line production capabilities, delivering quality and consistency for medical device manufacturers worldwide.

The company's participation in Medical Technology Ireland highlights its commitment to supporting global OEMs with advanced manufacturing solutions, while remaining closely connected to emerging trends and innovations within the medtech industry.

About Medical Components Specialists: Medical Components Specialists (MCS) is a contract manufacturer specializing in precision grinding for medical device OEMs worldwide. With over six decades of expertise, MCS provides orthopedic and interventional devices, tooling, and instrumentation trusted by global medical manufacturers. The company operates FDA-registered, ISO 13485-certified facilities, ensuring the highest standards of quality and reliability.

Contacts:
Grant Niewinski
Director of Business Development
[email protected]
312-607-5589

SOURCE: Medical Components Specialists, Inc.



View the original press release on ACCESS Newswire

F.M.Ferrentino--PV

Featured

Michigan Pizza Driver Halts $785K GoFundme After Viral Prank

Walt Zerod, a Michigan father of four who became the center of a viral online controversy, has paused a crowdfunding campaign that raised nearly $785,000. The Red Baron delivery driver announced on Thursday that he is closing the page to focus on his family during the holiday season.

Kate McClymont Testifies at Alan Jones Trial Over Reporting Methods

Investigative journalist Kate McClymont took the stand in the thirteenth week of the trial against former radio personality Alan Jones, facing rigorous cross-examination over her reporting methodology. Her testimony focused on text message exchanges with police and the verification process that led to the legal proceedings.

Chervon Names Doug Palmer Vice President of Finance - Canada

TORONTO, ON / ACCESS Newswire / November 5, 2026 / Effective November 9, 2026, Chervon names Doug Palmer Vice President of Finance - Canada, reporting to Neil Harrison, Vice President and Managing Director of Chervon Canada. He will also have a dotted-line reporting relationship to Ryan Wang, Chief Financial Officer, Chervon NA.

Polaris Renewable Energy Announces Q3 2026 Results

TORONTO, ON / ACCESS Newswire / November 5, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the three and nine months ended September 30, 2026. This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise.

Change text size: